The new batch of the vaccine from coronavirus developed by Oxford/AstraZeneca (CoviShield) will be shipped to Ukraine from India at the end of March as RBK Ukraine reported citing Health Minister of Ukraine Maksym Stepanov.
“The next batch of CoviShield vaccine in the amount of 1.5 million doses should arrive until March 31, according to the contract,” Stepanov noted.
According to him, permission for export from the government of India is needed for the receiving of the next batch of drug as all countries that have production capacities are restricted in export.
The health minister also refuted the danger of the AstraZeneca vaccine.
Earlier, it was reported that Ukraine is not going to suspend the vaccination campaign with the use of CoviShield drug produced by the Serum Institute of India.
As we reported, the European Medicines Agency (EMA) considers the reports on side effects of the AstraZeneca vaccine. The issue is about information from a few EU countries on the blood clots of some vaccinated people.
Due to the blood clots, some countries stopped the use of the AstraZeneca vaccine; particularly, Denmark, Austria, Estonia, Lithuania, Luxembourg, Latvia and Cyprus. Norway is not an EU member but it also stopped the use of AstraZeneca. Later, Bulgaria, Thailand and Romania joined this list. Soon, Ireland and the Netherlands also refused fro AstraZeneca’s use.
In Norway, three medics were hospitalized with blood clots. While a woman died after AstraZeneca shot in Croatia
Later, AstraZeneca Company stated its vaccine does not lead to blood clotting ability issues.